DS
GILD icon

DRW Securities’s Gilead Sciences GILD Stock Holding History

DRW Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-42,600
Closed -$2.53M – 283
2022
Q1 		$2.53M Buy
+42,600
New +$2.72M 0.07% 86
2014
Q1 		– Sell
-28,000
Closed -$2.1M – 166
2013
Q4 		$2.1M Hold
28,000
– – 0.09% 41
2013
Q3 		$1.92M Buy
+28,000
New +$1.67M 0.15% 40

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DRW Securities's GILD Position: Q2 2026 in Review

DRW Securities sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 3,207 shares — an estimated $438K sold.

DRW Securities first reported a position in GILD in Q3 2013 and held it in 17 quarters. The position peaked at $6.13M in Q4 2014. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • DRW Securities reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • DRW Securities sold 3,207 Gilead Sciences shares in Q2 2026, an estimated $438K.
  • DRW Securities first reported a position in Gilead Sciences in Q3 2013 and held it in 17 quarters.
  • DRW Securities's Gilead Sciences position peaked at $6.13M in Q4 2014.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.